abstract |
The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes. nAn exemplary embodiment is a human IgG Fc polypeptide variant comprising a tryptophan at position 308, wherein said variant exhibits increased binding to FcRn. |